¿Es schizosaccharomyces pombe extract seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety flags were found for Schizosaccharomyces pombe extract. Literature (general PubMed records on S. pombe as a microbiological model) does not report reproductive or developmental toxicity from topical cosmetic use; cosmetic databases (CosIng/PubChem entries for yeast/ferment extracts) treat this as a topical/biotech-derived extract. Given lack of evidence for reproductive hazard and expected negligible dermal systemic absorption of large-biopolymer extracts, default scores are 0. Sources consulted: ECHA Annex VI (no listing), PubMed, CosIng, PubChem.
Pregnancy-safe products containing schizosaccharomyces pombe extract
Related ingredients
Frequently asked questions
- ¿Es schizosaccharomyces pombe extract seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety flags were found for Schizosaccharomyces pombe extract. Literature (general PubMed records on S. pombe as a microbiological model) does not report reproductive or developmental toxicity from topical cosmetic use; cosmetic databases (CosIng/PubChem entries for yeast/ferment extracts) treat this as a topical/biotech-derived extract. Given lack of evidence for reproductive hazard and expected negligible dermal systemic absorption of large-biopolymer extracts, default scores are 0. Sources consulted: ECHA Annex VI (no listing), PubMed, CosIng, PubChem.
- ¿Es schizosaccharomyces pombe extract seguro durante la lactancia?
- No data indicating reproductive or lactation-related toxicity or systemic exposure that would affect breastfed infants. Yeast/ferment extracts are not identified as lactation hazards in available cosmetic/regulatory sources; therefore hazard and mechanism scores are 0 and dermal exposure is considered negligible for typical topical cosmetic use.
- ¿Es schizosaccharomyces pombe extract seguro para la piel del bebé?
- No infant-specific reproductive or developmental toxicity data were identified. Mechanism/hazard remain 0. Exposure score increased to 1 for 0–3 yr skin because infant skin has higher permeability and surface-area-to-weight, and although large biochemical extracts have low dermal bioavailability, neonatal barrier immaturity makes a low but measurable exposure plausible.
- ¿Cómo puntúa VeriMom a schizosaccharomyces pombe extract?
- VeriMom puntúa schizosaccharomyces pombe extract en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a schizosaccharomyces pombe extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a schizosaccharomyces pombe extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.


